Abstract
Introduction One in eight children in the United Kingdom are estimated to have a mental health condition, and many do not receive support or treatment. The COVID-19 pandemic appears to have exacerbated this issue. Prevalence of poor mental health is not evenly distributed across age-groups, by sex or socioeconomic groups. Equity in access to mental health care is a policy priority but relatively under-researched.
Methods We linked previously unlinked records for all mental health prescriptions and referrals to specialist mental health outpatient care between the years of 2015 and 2021 for children aged 2 to 17 years in a single NHS Scotland health board region. We analysed trends in prescribing, referrals, and acceptance to out-patient treatment over time, and measured differences in treatment and service use rates by age, sex, and area deprivation.
Results We identified 18,732 children with 178,657 mental health prescriptions and 21,874 referrals to specialist outpatient care. Prescriptions increased by 59% over the study period. Boys received double the prescriptions of girls and the rate of prescribing in the most deprived areas was double that in the least deprived. Referrals increased 9% overall. Initially, boys and girls both had an annual referral rate of 2.7 per 1,000, but this fell 6% for boys and rose 25% for girls. Referral rate for the youngest decreased 67% but increased 21% for the oldest. The proportion of rejected referrals increased steeply since 2020 from 17% to 30%. The proportion of referrals accepted for girls rose to 62% and the mean age increased 1.5 years.
Discussion The large increase in mental health prescribing and changes in referrals to specialist outpatient care aligns with emerging evidence of increasing poor mental health, particularly since the start of the COVID-19 pandemic. The static size of the population accepted for specialist treatment amid greater demand, and the changing demographics of those accepted, indicate clinical prioritisation and unmet need.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Health Foundation Networked Data Lab Programme.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The North Node Privacy Advisory Committee (NNPAC) gave ethical approval for this work (project ID: 6-063-21). NNPAC provides researchers with streamlined access to NHS Grampian data for research purposes and committee approval incorporates approvals from: the project sponsor, ethics panel, the NHS Grampian Caldicott Guardian, and NHS Grampian Research & Development.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
No changes to manuscript. Additional supplemental files added.
Data Availability
All analysis was carried out in the Grampian Data Safe Haven (project ID: DaSH477) on pseudonymised individual-level data. Per Scottish Safe Haven Charter, only aggregate data can be released from the Grampian Data Safe Haven for publication, but all individual-level data will be archived for 5 years on project completion and may be accessed by application to the Grampian Data Safe Haven (email dash{at}abdn.ac.uk) on condition that appropriate project approvals were secured. Following the archiving period this data will be deleted. Data analysis and figure generation was conducted using R (version 4.0.3) in RStudio (version 1.4.1103). All relevant analysis code files and summary data are available in the supplementary materials and are hosted on the project GitHub repository (https://github.com/AbdnCHDS/NDL_prescribing_referrals_paper).
